Tokyo, Aug. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062632) titled 'Study of nasogastric tube placement using a light-guided tube positioning system' on Aug. 20.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - Jichi Medical University

Condition: Condition - Hospitalized patients requiring nasogastric tube placement, irrespective of underlying disease Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate whether the use of a light-guided catheter system during nasogastric tube placement improves procedural operability and may allow omission of radiographic confirmation after tube placement. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - In patients clinically requiring nasogastric tube placement, the MET Light-Guided Catheter System is used concomitantly during nasogastric tube insertion and placement. The light-guided catheter is inserted into the nasogastric tube, and the position of the light source is assessed transcutaneously during and after tube placement. After tube placement, abdominal radiography is performed as part of standard clinical care, and the tube-tip position confirmed by radiography is compared with the position identified using the light-guided catheter system. The intervention is performed at each nasogastric tube placement procedure.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients aged 18 years or older who are clinically judged to require nasogastric tube placement and for whom written informed consent is obtained from the patient or an appropriate legally authorized representative. Key exclusion criteria - Patients for whom informed consent for participation in the study cannot be obtained. Patients with a cardiac pacemaker. Patients with an implantable cardioverter-defibrillator (ICD). Target Size - 880

Recruitment Status: Recruitment status - Enrolling by invitation Date of protocol fixation - 2023 Year 10 Month 18 Day Date of IRB - 2023 Year 10 Month 26 Day Anticipated trial start date - 2023 Year 10 Month 27 Day Last follow-up date - 2027 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071692

Disclaimer: Curated by HT Syndication.